Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Yes, a case report describes a patient with metastatic uveal melanoma who achieved durable disease control after adding SBRT to tebentafusp, with a partial response and 35 months…
Prolgolimab plus chemotherapy showed the strongest overall survival benefit in a 2025 phase III trial, while network meta-analysis also ranked pembrolizumab and cemiplimab plus…
Genetic factors increase a child's risk of chronic otitis media by altering immune system responses and middle ear function, with specific gene variants on chromosome 19…
Yes, bone conduction hearing devices significantly improve health-related quality of life for adults with chronic otitis media, based on systematic reviews and clinical studies.
Yes, a case report shows tebentafusp plus SBRT controlled metastatic uveal melanoma for over 35 months, but more research is needed to confirm this approach.
Immunoembolization shows lower disease control rates than the FOCUS trial for liver-dominant metastatic uveal melanoma, though tebentafusp combined with radiotherapy may offer…
A meta-analysis found no significant difference in hospital length of stay between high-dose and low-dose ceftriaxone for non-CNS infections.
ATRA plus ATO for APL achieves 3-year overall survival of 95% and 10-year survival of ≥80%, with complete remission rates over 95%.
An AI tool shows very high accuracy for distinguishing Acute Promyelocytic Leukemia (APL) from other leukemias, with an AUROC of 0.98 in international tests, though it currently…
Frontline ATRA-ATO therapy is highly effective for newly diagnosed APL, with complete remission rates over 94% and 3-year survival above 93% in clinical trials.
Yes, the rate of oral and pharyngeal HPV-associated cancer increased in the US between 2007 and 2016, likely driven by rising HPV-related cases.
Becotatug vedotin showed a 20.9% objective response rate in recurrent or metastatic head and neck squamous cell carcinoma after prior therapy.
Short-course beta-lactam antibiotics can reduce early lung infections in ventilated brain injury patients, but they do not prevent late-onset infections or lower death rates.
Treatment for hypertriglyceridemia in pregnancy starts with strict low-fat diet and lifestyle changes; severe cases may require insulin, plasma exchange, or rarely fibrates under…
Yes, plozasiran reduces the risk of recurrent pancreatitis in severe hypertriglyceridemia by 83% based on a post hoc analysis of the PALISADE trial.
Yes, darolutamide combination therapy improves survival in metastatic hormone-sensitive prostate cancer, with a 32% reduction in risk of death when added to ADT plus docetaxel.
Yes, darolutamide plus ADT significantly delays pain progression in metastatic hormone-sensitive prostate cancer, based on the ARANOTE phase 3 trial.
Yes, cohort studies are the most common study type in pediatric ARI research, providing key data on pathogen profiles, co-infections, seasonal patterns, and clinical outcomes…
EBUS-guided transbronchial mediastinal cryobiopsy (EBUS-TBMC) has the highest diagnostic yield for lymphoma in the mediastinum, outperforming standard EBUS-TBNA.
No, olezarsen did not significantly reduce noncalcified plaque volume over 12 months in adults with moderate hypertriglyceridemia, despite lowering triglycerides by ~60%.
No, Frexalimab, Brivekimig, and Rilzabrutinib are not being tested together. A current Phase 2 study tests these drugs individually against a placebo to see which one reduces…
Yes, cerebral infarction is common in children with tuberculous meningitis, especially in severe disease, with rates up to 50% in some studies.
Yes, arterial occlusion is a key mechanism linking cerebral infarction to disease severity in tuberculous meningitis, as shown by a secondary analysis of the ACT-TBM trial.
Yes, obinutuzumab has shown promise in case reports and small studies for FSGS patients who did not respond to rituximab, but larger trials are needed.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.